(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LRP4 mRNA] CTD PMID:31150632 1,2-dichloroethane decreases expression ISO RGD:1331974 6480464 ethylene dichloride results in decreased expression of LRP4 mRNA CTD PMID:28189721 , PMID:28960355 17beta-estradiol multiple interactions ISO RGD:731744 6480464 [Estradiol co-treated with Progesterone] results in increased expression of LRP4 mRNA CTD PMID:20660070 17beta-estradiol increases expression ISO RGD:731744 6480464 Estradiol results in increased expression of LRP4 mRNA CTD PMID:31614463 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of LRP4 mRNA CTD PMID:32145629 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:731744 6480464 Dihydrotestosterone results in increased expression of LRP4 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1331974 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1331974 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of LRP4 mRNA more ... CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731744 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of LRP4 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731744 6480464 Tetrachlorodibenzodioxin results in increased expression of LRP4 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1331974 6480464 Tetrachlorodibenzodioxin results in increased expression of LRP4 mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1331974 6480464 Tetrachlorodibenzodioxin affects the expression of LRP4 mRNA CTD PMID:21570461 , PMID:26377647 2-hydroxypropanoic acid decreases expression ISO RGD:731744 6480464 Lactic Acid results in decreased expression of LRP4 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1331974 6480464 tetrabromobisphenol A results in decreased expression of LRP4 mRNA CTD PMID:25172293 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1331974 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of LRP4 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide increases expression ISO RGD:1331974 6480464 Fenretinide results in increased expression of LRP4 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LRP4 mRNA CTD PMID:24780913 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of LRP4 mRNA CTD PMID:20488242 all-trans-retinoic acid decreases expression ISO RGD:731744 6480464 Tretinoin results in decreased expression of LRP4 mRNA CTD PMID:23724009 , PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LRP4 mRNA CTD PMID:16483693 antimycin A decreases expression ISO RGD:731744 6480464 Antimycin A results in decreased expression of LRP4 mRNA CTD PMID:33512557 antirheumatic drug increases expression ISO RGD:731744 6480464 Antirheumatic Agents results in increased expression of LRP4 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:731744 6480464 Arsenic affects the methylation of LRP4 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:731744 6480464 Arsenic affects the methylation of LRP4 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:731744 6480464 Arsenic Trioxide results in increased expression of LRP4 mRNA CTD PMID:20458559 aspartame multiple interactions ISO RGD:1331974 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP4 mRNA CTD PMID:23783067 benzo[a]pyrene increases expression ISO RGD:1331974 6480464 Benzo(a)pyrene results in increased expression of LRP4 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:731744 6480464 Benzo(a)pyrene affects the methylation of LRP4 intron, Benzo(a)pyrene affects the methylation of LRP4 promoter CTD PMID:27901495 , PMID:30157460 Benzo[ghi]perylene increases expression ISO RGD:1331974 6480464 1, 12-benzoperylene results in increased expression of LRP4 mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases expression ISO RGD:1331974 6480464 benzo(k)fluoranthene results in increased expression of LRP4 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1331974 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:731744 6480464 Diethylhexyl Phthalate results in decreased expression of LRP4 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LRP4 mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO RGD:731744 6480464 bisphenol A results in increased expression of LRP4 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1331974 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 caffeine decreases phosphorylation ISO RGD:731744 6480464 Caffeine results in decreased phosphorylation of LRP4 protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:731744 6480464 Calcitriol results in decreased expression of LRP4 mRNA CTD PMID:26485663 carbamazepine affects expression ISO RGD:731744 6480464 Carbamazepine affects the expression of LRP4 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1331974 6480464 Nanotubes, Carbon results in decreased expression of LRP4 mRNA CTD PMID:25554681 , PMID:25620056 cisplatin increases expression ISO RGD:731744 6480464 Cisplatin results in increased expression of LRP4 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:731744 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of LRP4 mRNA CTD PMID:27392435 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of LRP4 mRNA CTD PMID:24386269 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of LRP4 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO RGD:1331974 6480464 Cyclosporine results in decreased expression of LRP4 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:731744 6480464 Cyclosporine results in decreased expression of LRP4 mRNA CTD PMID:25562108 deguelin increases expression ISO RGD:731744 6480464 deguelin results in increased expression of LRP4 mRNA CTD PMID:33512557 diarsenic trioxide increases expression ISO RGD:731744 6480464 Arsenic Trioxide results in increased expression of LRP4 mRNA CTD PMID:20458559 dibenzofurans increases expression ISO RGD:1331974 6480464 Dibenzofurans results in increased expression of LRP4 mRNA CTD PMID:34254344 dicrotophos increases expression ISO RGD:731744 6480464 dicrotophos results in increased expression of LRP4 mRNA CTD PMID:28302478 dioxygen multiple interactions ISO RGD:1331974 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRP4 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:731744 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 epoxiconazole affects expression ISO RGD:1331974 6480464 epoxiconazole affects the expression of LRP4 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:731744 6480464 Ethanol results in increased expression of LRP4 mRNA CTD PMID:28986285 ethanol increases expression ISO RGD:1331974 6480464 Ethanol results in increased expression of LRP4 mRNA CTD PMID:30319688 fenthion decreases expression ISO RGD:1331974 6480464 Fenthion results in decreased expression of LRP4 mRNA CTD PMID:34813904 folic acid increases expression ISO RGD:1331974 6480464 Folic Acid results in increased expression of LRP4 mRNA CTD PMID:25629700 genistein increases expression EXP 6480464 Genistein results in increased expression of LRP4 mRNA CTD PMID:17341692 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of LRP4 mRNA CTD PMID:33387578 lead diacetate increases expression ISO RGD:1331974 6480464 lead acetate results in increased expression of LRP4 mRNA CTD PMID:20542052 leflunomide increases expression ISO RGD:731744 6480464 leflunomide results in increased expression of LRP4 mRNA CTD PMID:28988120 maneb multiple interactions ISO RGD:1331974 6480464 [Paraquat co-treated with Maneb] affects the expression of LRP4 mRNA CTD PMID:22563483 metacetamol decreases expression ISO RGD:1331974 6480464 3-hydroxyacetanilide results in decreased expression of LRP4 mRNA CTD PMID:18544908 methidathion decreases expression ISO RGD:1331974 6480464 methidathion results in decreased expression of LRP4 mRNA CTD PMID:34813904 methylmercury chloride affects expression EXP 6480464 methylmercuric chloride affects the expression of LRP4 mRNA CTD PMID:20864626 monosodium L-glutamate multiple interactions ISO RGD:1331974 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP4 mRNA CTD PMID:23783067 nickel atom decreases expression ISO RGD:731744 6480464 Nickel results in decreased expression of LRP4 mRNA CTD PMID:24768652 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of LRP4 mRNA CTD PMID:25729387 paracetamol decreases expression ISO RGD:1331974 6480464 Acetaminophen results in decreased expression of LRP4 mRNA CTD PMID:18544908 paracetamol increases expression ISO RGD:731744 6480464 Acetaminophen results in increased expression of LRP4 mRNA CTD PMID:22230336 paraquat increases expression ISO RGD:1331974 6480464 Paraquat results in increased expression of LRP4 mRNA CTD PMID:22563483 paraquat multiple interactions ISO RGD:1331974 6480464 [Paraquat co-treated with Maneb] affects the expression of LRP4 mRNA CTD PMID:22563483 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of LRP4 mRNA CTD PMID:16221955 picoxystrobin decreases expression ISO RGD:731744 6480464 picoxystrobin results in decreased expression of LRP4 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1331974 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LRP4 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1331974 6480464 pirinixic acid results in increased expression of LRP4 mRNA CTD PMID:18301758 , PMID:23811191 progesterone multiple interactions ISO RGD:731744 6480464 [Estradiol co-treated with Progesterone] results in increased expression of LRP4 mRNA CTD PMID:20660070 pyridaben increases expression ISO RGD:1331974 6480464 pyridaben results in increased expression of LRP4 mRNA CTD PMID:22563483 rac-lactic acid decreases expression ISO RGD:731744 6480464 Lactic Acid results in decreased expression of LRP4 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:731744 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of LRP4 mRNA CTD PMID:23557933 rotenone increases expression ISO RGD:731744 6480464 Rotenone results in increased expression of LRP4 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:731744 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 tetrachloromethane affects expression ISO RGD:1331974 6480464 Carbon Tetrachloride affects the expression of LRP4 mRNA CTD PMID:17484886 tetrachloromethane decreases expression ISO RGD:1331974 6480464 Carbon Tetrachloride results in decreased expression of LRP4 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LRP4 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of LRP4 mRNA CTD PMID:31150632 tetracycline decreases expression ISO RGD:1331974 6480464 Tetracycline results in decreased expression of LRP4 mRNA CTD PMID:16917069 thapsigargin decreases expression ISO RGD:731744 6480464 Thapsigargin results in decreased expression of LRP4 mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of LRP4 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1331974 6480464 titanium dioxide results in increased expression of LRP4 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of LRP4 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:731744 6480464 trichostatin A results in increased expression of LRP4 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:731744 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP4 mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO RGD:1331974 6480464 trimellitic anhydride results in decreased expression of LRP4 mRNA CTD PMID:19042947 tunicamycin decreases expression ISO RGD:731744 6480464 Tunicamycin results in decreased expression of LRP4 mRNA CTD PMID:22378314 valproic acid increases expression ISO RGD:731744 6480464 Valproic Acid results in increased expression of LRP4 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:731744 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP4 mRNA CTD PMID:27188386 vorinostat multiple interactions ISO RGD:731744 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP4 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:731744 6480464 vorinostat results in increased expression of LRP4 mRNA CTD PMID:26272509